vs
Adeia Inc.（ADEA）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Adeia Inc.的1.1倍（$197.9M vs $182.6M），Adeia Inc.净利率更高（40.4% vs 6.7%，领先33.6%），Adeia Inc.同比增速更快（53.3% vs 13.6%），过去两年Adeia Inc.的营收复合增速更高（44.6% vs 14.4%）
Adeia Inc.是一家全球化知识产权授权与创新企业，主营半导体制造、消费电子、媒体分发及智能设备领域的专利技术研发与商业化合作，与全球多家头部科技企业达成授权合作，推动相关行业技术升级。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ADEA vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$182.6M
营收增速更快
ADEA
高出39.6%
13.6%
净利率更高
ADEA
高出33.6%
6.7%
两年增速更快
ADEA
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $182.6M | $197.9M |
| 净利润 | $73.7M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 59.5% | 9.0% |
| 净利率 | 40.4% | 6.7% |
| 营收同比 | 53.3% | 13.6% |
| 净利润同比 | 104.6% | 143.9% |
| 每股收益（稀释后） | $0.65 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADEARGEN
| Q1 26 | $182.6M | — | ||
| Q4 25 | $182.6M | $197.9M | ||
| Q3 25 | $87.3M | $188.8M | ||
| Q2 25 | $85.7M | $182.4M | ||
| Q1 25 | $87.7M | $169.2M | ||
| Q4 24 | $119.2M | $174.1M | ||
| Q3 24 | $86.1M | $154.9M | ||
| Q2 24 | $87.3M | $154.1M |
净利润ADEARGEN
| Q1 26 | $73.7M | — | ||
| Q4 25 | $73.7M | $13.3M | ||
| Q3 25 | $8.8M | $14.9M | ||
| Q2 25 | $16.7M | $14.9M | ||
| Q1 25 | $11.8M | $5.8M | ||
| Q4 24 | $36.0M | $-30.3M | ||
| Q3 24 | $19.3M | $-654.0K | ||
| Q2 24 | $8.4M | $3.3M |
毛利率ADEARGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率ADEARGEN
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.5% | 9.0% | ||
| Q3 25 | 30.9% | 8.9% | ||
| Q2 25 | 19.1% | 7.6% | ||
| Q1 25 | 26.0% | 3.9% | ||
| Q4 24 | 48.2% | -17.7% | ||
| Q3 24 | 32.7% | -5.1% | ||
| Q2 24 | 27.1% | 1.0% |
净利率ADEARGEN
| Q1 26 | 40.4% | — | ||
| Q4 25 | 40.4% | 6.7% | ||
| Q3 25 | 10.1% | 7.9% | ||
| Q2 25 | 19.5% | 8.2% | ||
| Q1 25 | 13.5% | 3.4% | ||
| Q4 24 | 30.2% | -17.4% | ||
| Q3 24 | 22.4% | -0.4% | ||
| Q2 24 | 9.6% | 2.2% |
每股收益（稀释后）ADEARGEN
| Q1 26 | $0.65 | — | ||
| Q4 25 | $0.66 | $0.24 | ||
| Q3 25 | $0.08 | $0.26 | ||
| Q2 25 | $0.15 | $0.26 | ||
| Q1 25 | $0.10 | $0.10 | ||
| Q4 24 | $0.32 | $-0.55 | ||
| Q3 24 | $0.17 | $-0.01 | ||
| Q2 24 | $0.07 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.1M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | — | $2.1B |
| 总资产 | $1.0B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ADEARGEN
| Q1 26 | $73.1M | — | ||
| Q4 25 | $136.7M | $767.6M | ||
| Q3 25 | $115.1M | $748.7M | ||
| Q2 25 | $116.5M | $708.9M | ||
| Q1 25 | $116.5M | $697.2M | ||
| Q4 24 | $110.4M | $757.4M | ||
| Q3 24 | $89.2M | $784.0M | ||
| Q2 24 | $94.5M | $809.1M |
总债务ADEARGEN
| Q1 26 | — | — | ||
| Q4 25 | $418.5M | $542.2M | ||
| Q3 25 | $438.7M | $537.9M | ||
| Q2 25 | $448.9M | — | ||
| Q1 25 | $459.2M | — | ||
| Q4 24 | $475.5M | $525.6M | ||
| Q3 24 | $524.4M | — | ||
| Q2 24 | $535.6M | — |
股东权益ADEARGEN
| Q1 26 | — | — | ||
| Q4 25 | $480.5M | $2.1B | ||
| Q3 25 | $413.7M | $2.1B | ||
| Q2 25 | $402.9M | $2.1B | ||
| Q1 25 | $389.5M | $2.0B | ||
| Q4 24 | $396.6M | $2.0B | ||
| Q3 24 | $378.2M | $2.0B | ||
| Q2 24 | $359.1M | $2.0B |
总资产ADEARGEN
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $2.9B | ||
| Q3 25 | $1.1B | $2.9B | ||
| Q2 25 | $1.1B | $2.9B | ||
| Q1 25 | $1.1B | $2.9B | ||
| Q4 24 | $1.1B | $2.8B | ||
| Q3 24 | $1.1B | $2.8B | ||
| Q2 24 | $1.1B | $2.9B |
负债/权益比ADEARGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.87× | 0.26× | ||
| Q3 25 | 1.06× | 0.26× | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 1.18× | — | ||
| Q4 24 | 1.20× | 0.27× | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | 1.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $158.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 2.14× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流ADEARGEN
| Q1 26 | $158.1M | — | ||
| Q4 25 | $60.0M | $25.7M | ||
| Q3 25 | $17.8M | $48.1M | ||
| Q2 25 | $23.1M | $28.6M | ||
| Q1 25 | $57.1M | $15.0M | ||
| Q4 24 | $107.5M | $39.2M | ||
| Q3 24 | $14.3M | $49.3M | ||
| Q2 24 | $23.5M | $42.2M |
自由现金流ADEARGEN
| Q1 26 | — | — | ||
| Q4 25 | $59.4M | $17.6M | ||
| Q3 25 | $17.0M | $43.4M | ||
| Q2 25 | $22.9M | $21.5M | ||
| Q1 25 | $56.9M | $11.4M | ||
| Q4 24 | $106.9M | $33.6M | ||
| Q3 24 | $14.3M | $42.3M | ||
| Q2 24 | $23.0M | $37.4M |
自由现金流率ADEARGEN
| Q1 26 | — | — | ||
| Q4 25 | 32.5% | 8.9% | ||
| Q3 25 | 19.5% | 23.0% | ||
| Q2 25 | 26.7% | 11.8% | ||
| Q1 25 | 64.9% | 6.8% | ||
| Q4 24 | 89.7% | 19.3% | ||
| Q3 24 | 16.6% | 27.3% | ||
| Q2 24 | 26.4% | 24.3% |
资本支出强度ADEARGEN
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 4.1% | ||
| Q3 25 | 0.9% | 2.5% | ||
| Q2 25 | 0.2% | 3.9% | ||
| Q1 25 | 0.3% | 2.1% | ||
| Q4 24 | 0.5% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 0.5% | 3.1% |
现金转化率ADEARGEN
| Q1 26 | 2.14× | — | ||
| Q4 25 | 0.81× | 1.93× | ||
| Q3 25 | 2.02× | 3.23× | ||
| Q2 25 | 1.38× | 1.92× | ||
| Q1 25 | 4.84× | 2.57× | ||
| Q4 24 | 2.98× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 2.80× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
